Gut Microbiota Variations between Henoch-Schonlein Purpura and Henoch-Schonlein Purpura Nephritis

Fang Zhou1, Qimin Shao1, Lihong Jia1

  • 1Department of Rheumatoid Immune Nephrology, Hangzhou Children's Hospital, Hangzhou, 310014 Zhejiang, China.

Insights

Children with Henoch-Schonlein purpura (HSP) and HSP nephritis (HSPN) show altered gut microbiota compared to healthy children. This suggests potential for microbe-based therapies to improve outcomes for these conditions.

Area of Science:

  • Microbiology
  • Pediatrics
  • Gastroenterology

Background:

  • Gut microbiota differences between children with Henoch-Schonlein purpura (HSP) and HSP nephritis (HSPN) are not well understood in China.
  • HSP is an autoimmune disease causing inflammation in small blood vessels, often affecting the skin, joints, and kidneys.

Purpose of the Study:

  • To investigate and compare the gut microbiota composition in children diagnosed with HSP, HSPN, and healthy controls.
  • To identify potential microbial biomarkers associated with HSP and HSPN in pediatric populations.

Main Methods:

  • Recruited three groups of 25 children: HSP, HSPN, and healthy controls.
  • Analyzed fecal samples using 16S rRNA gene sequencing (V3-V4 region).
  • Compared gut microbial diversity and abundance between the groups.

Main Results:

  • Significant differences in gut microbial diversity were observed between the three groups (P = 0.0224).
  • Children with HSP exhibited lower Bifidobacterium abundance compared to healthy children and those with HSPN.
  • HSPN patients showed reduced Akkermansia and increased Alistipes abundance relative to HSP patients.

Conclusions:

  • The study indicates gut microbiota dysbiosis in children with HSP and HSPN.
  • Findings suggest that gut microbiota alterations may play a role in the pathogenesis of HSP and HSPN.
  • Results support the potential development of microbiome-targeted therapies for managing or preventing pediatric HSP and HSPN.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
215
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
76